Cyprumed is a drug delivery company with strong focus on oral delivery of peptide drugs.
Delta4: using AI to tap into the pentabytes of available data to de-risk pharma decisions. Delta4 is a TechBio company focused on helping clients expand indications for existing drugs with known safety profiles. By leveraging Hyper-C, a proprietary artificial intelligence-powered platform, the team of computational biologists at Delta4 detects beneficial drug-indication relationships with unprecedented speed, accuracy, and efficiency.
Technology transfer, pharmaceutical development for solid dosage forms (tablet, granulates, a.o.) for clinical studies, liquids and creams. Study development and monitoring (Phase I-II), CRO biomarker development for inflammatory and autoimmun diseases, product management for pharmacies, licensing and marketing
EcoSafe GmbH is a biotechnology company with the aim of developing microbial active ingredients from insect-pathogenic fungi for use in the fields of plant protection, veterinary and human medicine. Under special conditions, insect-pathogenic fungi can be stimulated to form metabolic products with a very strong effect against insects and mites. The company's aim is to develop these active substances for practical application.
enGenes Biotech develops customized solutions for the cost-effective production of recombinant proteins and plasmid DNA in microbial expression systems. The company’s unique, proprietary, E. coli-based enGenes-X-press technology platform achieves outstanding yields of soluble and active recombinant protein or plasmid DNA by reducing biological complexity. This is achieved by decoupling biomass growth from product formation.
EURRUS Biotech GmbH ("Eurrus") is incorporated in Tulln, Austria. Founded in 2006 the existing partners joined in 2012. Development focus is Asthma with a newly developed API. Development status has reached CP IIb.